Novan CEO Discusses Its HPV Drug And Clinical Trial Results
December 09, 2016 at 15:41 PM EST
Novan Inc (NASDAQ: NOVN) is a small-cap late-stage pharmaceutical company focused on the treatment of acne vulgaris, external genital ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.